Pharmaceuticals, Biotechnology and Life Sciences
– Katherine Vega Stultz appointed as chief operating officer – Philip P. Gutry appointed as chief business officer and head…
FARGO, N.D.–(BUSINESS WIRE)–#Aldevron–Aldevron, a global leader in the manufacture of plasmid DNA, mRNA and proteins, today announced Shawn McCormick as…
– Confirmed overall response rate (ORR) of 21% in the Phase 1b dose-escalation stage across all doses, with 1 complete…
Room-temperature stable formulation aids timely point-of-care administration PAOLI, Pa.–(BUSINESS WIRE)–Sedor Pharmaceuticals, LLC (Sedor) today announced that the U.S. Food and…
– Data from melanoma and SCCHN cohorts demonstrate eganelisib was well tolerated in combination with Opdivo® – – Translational data…
Ye (Sally) Wang Appointed Chairwoman of the Board Ying Huang Named CEO SOMERSET, N.J.–(BUSINESS WIRE)–Legend Biotech Corporation (NASDAQ: LEGN) (“Legend…
IK-175 is an Orally Active Aryl Hydrocarbon Receptor Antagonist That Inhibits Tumor Growth and Reverses Immune Suppression in Mouse Tumor…
Data suggest that PVSRIPO, either alone or in combination with anti-PD-1, holds promise for patients with anti-PD-1 refractory melanoma Intratumoral…
– SNS-301 demonstrated prolonged partial response and improvement in immune markers in PD-L1 negative disease patient with 43% tumor reduction…
– Pivotal GEM-3 study of B-VEC in DEB expected to complete enrollment in early 2021 – Initiated the Phase 1…